O'Brart David P S, Shalchi Zaid, McDonald Robert J, Patel Parul, Archer Timothy J, Marshall John
Keratoconus Research Institute, Department of Ophthalmology, St. Thomas' Hospital, London, United Kingdom.
Keratoconus Research Institute, Department of Ophthalmology, St. Thomas' Hospital, London, United Kingdom.
Am J Ophthalmol. 2014 Oct;158(4):651-663.e1. doi: 10.1016/j.ajo.2014.06.013. Epub 2014 Jun 25.
To investigate the 20-year efficacy and safety of photorefractive keratectomy (PRK).
Long-term observational case series.
In the setting of a university hospital, a study population of 42 patients (42 eyes) who had, as part of a randomized prospective trial, undergone PRK 20 years previously were studied. All had received -3.0 or -6.0 diopter (D) corrections with either 5.0 or 6.0 mm optical zones or a multizone treatment. The mean preoperative spherical equivalent refractive error (SEQ) was -5.13 D (range, -2.75 to -8.0 D). The outcome measures included visual acuity, refractive error, corneal topography and axial length.
Between 1 and 20 years there was an increase in mean myopic SEQ of -0.54 D (P < 0.02). In patients younger than 40 years of age at time of correction, this increase was -0.92 D (P < 0.002) with an accompanying increase in variance (P < 0.02), whereas in those older than 40 it was -0.08D (P = 0.8). In female patients the change was -0.69D (P < 0.01), while in males it was -0.26D (P = 0.6). The efficacy index at 20 years was 0.49, and the safety index was 0.97. Corrected distance visual acuity improved between 1 and 20 years (P < 0.01); 93% of corneas were clear at 20 years; 3 eyes had trace haze. There was an improvement in haze scores between 1 and 20 years (P < 0.02). Cornea power remained unchanged between 6 months and 20 years (P = 0.4). Axial length increased by a mean of 0.84 mm (P < 0.0001). There was no ectasia.
There was a slight but significant increase in myopic SEQ after PRK between 1 and 20 years, particularly in those under 40 at the time of treatment and in female patients. Corneal power remained unchanged, but axial length increased. The procedure was safe, with no long-term sight-threatening complications and with improvements in corrected distance visual acuity and corneal transparency with time.
研究准分子激光角膜切削术(PRK)的20年疗效及安全性。
长期观察性病例系列。
在一所大学医院,对42例患者(42只眼)进行研究,这些患者在20年前作为一项随机前瞻性试验的一部分接受了PRK手术。所有患者均接受了-3.0或-6.0屈光度(D)的矫正,光学区直径为5.0或6.0毫米,或采用多区治疗。术前平均等效球镜度(SEQ)为-5.13 D(范围为-2.75至-8.0 D)。观察指标包括视力、屈光不正、角膜地形图和眼轴长度。
在1至20年期间,平均近视SEQ增加了-0.54 D(P < 0.02)。在矫正时年龄小于40岁的患者中,这种增加为-0.92 D(P < 0.002),同时方差增加(P < 0.02),而在40岁以上的患者中为-0.08 D(P = 0.8)。女性患者的变化为-0.69 D(P < 0.01),男性患者为-0.26 D(P = 0.6)。20年时的疗效指数为0.49,安全指数为0.97。矫正远视力在1至20年期间有所改善(P < 0.01);20年时93%的角膜透明;3只眼有微量 haze。1至20年期间haze评分有所改善(P < 0.02)。角膜屈光力在6个月至20年期间保持不变(P = 0.4)。眼轴长度平均增加了0.84毫米(P < 0.0001)。没有发生角膜扩张。
PRK术后1至20年,近视SEQ有轻微但显著的增加,特别是在治疗时年龄小于40岁的患者和女性患者中。角膜屈光力保持不变,但眼轴长度增加。该手术是安全的,没有长期威胁视力的并发症,随着时间的推移,矫正远视力和角膜透明度有所改善。